Frequently Asked Questions about Hip Dysplasia

Reading time: 2 min

Yes. Hip dysplasia has a significant genetic component. Children with a family history of congenital dysplasia or dislocation are at higher risk of developing it.

Early symptoms include groin pain and joint stiffness, which worsen with prolonged physical activity. In some cases, a limp may also develop.

Maintaining a healthy weight, performing low-impact exercises and avoiding activities that put excessive stress on the hip can help slow the progression of the disease.

Recommended exercises include swimming, cycling and yoga. These activities improve joint stability without overloading the hip.

Yes. Most patients who undergo periacetabular osteotomy can return to an active life after recovery; although it may be necessary to avoid high-impact sports.

In mild cases, physical therapy and lifestyle changes may be sufficient. However, in more severe cases, surgery is the best option to prevent future complications.

Periacetabular osteotomy has a high success rate. Between 60-80% of patients still have their natural hip after 20 years, without any need to replace it.

The most common complications of hip dysplasia treatment include femoral cutaneous nerve dysesthesia -  which causes numbness or a tingling sensation in the front and side of the thigh - and ectopic bone formation, which is bone growth outside the joint.

Both of these complications are generally manageable and do not usually significantly affect the final outcome of the treatment or the patient's recovery.

Recovery time varies, but it generally takes 3-6 months to return to normal daily activities and up to a year for full recovery.

Yes. With early detection and treatment, periacetabular osteotomy can delay or prevent the need for hip replacement.

Substantiated information by:

Jenaro A. Fernández-Valencia Laborde
Luis Ramírez Núñez

Published: 28 January 2025
Updated: 30 January 2025

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.

Subscribe

Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.

Hip Dysplasia related news